MDXG logo

MDXG
Mimedx Group Inc

4,776
Mkt Cap
$1.04B
Volume
450,485.00
52W High
$9.71
52W Low
$5.79
PE Ratio
25.57
MDXG Fundamentals
Price
$7.16
Prev Close
$6.98
Open
$7.06
50D MA
$7.00
Beta
0.92
Avg. Volume
919,733.95
EPS (Annual)
$0.2846
P/B
4.33
Rev/Employee
$416,820.79
Loading...
Loading...
News
all
press releases
Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG
Divisadero Street Capital Management LP lifted its position in shares of MiMedx Group, Inc (NASDAQ:MDXG - Free Report) by 362.9% during the second quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG
Trigran Investments Inc. grew its holdings in MiMedx Group, Inc (NASDAQ:MDXG - Free Report) by 10.4% during the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
MiMedx Group (NASDAQ:MDXG) Stock Price Down 5.6% - What's Next?
MiMedx Group (NASDAQ:MDXG) Trading Down 5.6% - What's Next...
MarketBeat·22d ago
News Placeholder
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?
Is it a good or bad thing when a stock experiences a golden cross technical event?
Zacks·24d ago
News Placeholder
Kimberly Maersk-Moller Sells 58,300 Shares of MiMedx Group (NASDAQ:MDXG) Stock
MiMedx Group, Inc (NASDAQ:MDXG - Get Free Report) insider Kimberly Maersk-Moller sold 58,300 shares of the firm's stock in a transaction that occurred on Thursday, November 6th. The shares were sold...
MarketBeat·30d ago
News Placeholder
FY2026 EPS Estimates for MiMedx Group Reduced by Analyst
MiMedx Group, Inc (NASDAQ:MDXG - Free Report) - Stock analysts at Northland Capmk decreased their FY2026 EPS estimates for shares of MiMedx Group in a note issued to investors on Monday, November...
MarketBeat·1mo ago
News Placeholder
Wall Street Analysts Predict a 64.86% Upside in MiMedx (MDXG): Here's What You Should Know
The mean of analysts' price targets for MiMedx (MDXG) points to a 64.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·1mo ago
News Placeholder
MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +114.29% and +19.99%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +66.67% and +10.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending
Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% after the Centers for Medicare&Medicaid Services (CMS) proposed a rule that would drastically cut Medicare spending on skin substitutes.
investing.com·5mo ago

Latest MDXG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.